GBA1 and Parkinson disease: It is interesting to note that, oppositely, regarding the number of DEGs attributed to a presence of GBA mutations revealed in our preset study, RNA-seq conducted in LRRK2 G2019S mutation carriers suggested that G2019S mutation in the LRRK2 gene markedly altered blood transcriptome in comparison with sporadic PD [14].